超越数字:抗苗勒管激素与窦卵泡计数并非体外受精联合胚胎植入前非整倍体遗传学检测中胚胎整倍体的独立预测因子
美国大型不孕症诊所网络回顾性队列研究,纳入2016年10月至2024年8月间13451个IVF联合PGT-A周期(11473例女性),按Bologna标准将AMH和AFC分层。调整后整倍体率在最低AMH组轻度升高(RR 1.08),最高AMH组相似(RR 1.00),AFC>16组略低(RR 0.96);AMH和AFC均与活产、临床妊娠、种植率无显著关联。
要点
- AMH和AFC各分层间整倍体率相近,调整后差异幅度小。
- AMH和AFC水平与活产、临床妊娠及种植率均无显著关联。
- 作者认为AMH和AFC评估卵巢储备有用,但独立预测胚胎整倍体价值有限。
核心结论
- 与近期研究相反,较低的AMH和AFC水平与胚胎整倍体率或活产结局的临床显著下降无关。
- 作者认为AMH和AFC虽可用于评估卵巢储备,但在不考虑母亲年龄等其他因素时,独立预测胚胎整倍体的价值可能有限。
研究设计与样本
- 回顾性队列研究,纳入美国大型不孕症诊所网络2016年10月至2024年8月间13451个IVF联合PGT-A周期,共11473例女性。
- 暴露为取卵前6个月内记录的AMH和AFC值,按Bologna标准分层:AMH<1.1、1.1-4.0、>4.0 ng/mL;AFC<7、7-16、>16。
主要发现
- 各AMH分层整倍体率相近:AMH<1.1组56.9%,1.1-4.0组54.0%,>4.0组55.8%。
- 各AFC分层整倍体率相近:AFC<7组56.3%,7-16组54.8%,>16组54.9%。
- 调整后最低AMH组整倍体轻度升高(RR 1.08;95%CI 1.05,1.11),最高AMH组相似(RR 1.00;95%CI 0.98,1.02)。
- 调整后AFC<7与7-16组整倍体相近(RR 1.00;95%CI 0.98,1.03),AFC>16组略低(RR 0.96;95%CI 0.95,0.98)。
- AMH和AFC水平均与活产、临床妊娠、种植率无显著关联。
临床怎么用
- 作者认为AMH和AFC可用于评估卵巢储备,但独立预测胚胎整倍体的价值可能有限。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the association between antimüllerian hormone (AMH) and antral follicle count (AFC) with embryo euploidy rates in patients undergoing in vitro fertilization (IVF) with preimplantation genetic testing for aneuploidy (PGT-A), independent of maternal age and other confounding factors. DESIGN: Retrospective cohort study. SUBJECTS: A total of 11,473 women who underwent 13,451 IVF cycles with PGT-A between October 2016 and August 2024 across a large national network of infertility clinics in the United States. EXPOSURE: Values of AMH and AFC recorded within 6 months of oocyte retrieval. Both AMH and AFC were categorized on the basis of Bologna criteria for diminished ovarian reserve: AMH <1.1, 1.1-4.0, and >4.0 ng/mL; AFC <7, 7-16, and >16. MAIN OUTCOME MEASURES: Adjusted relative risk (RR) of embryo euploidy on the basis of AMH and AFC levels, with secondary outcomes including live birth, clinical pregnancy, and implantation rates. RESULTS: Euploidy rates were comparable across AMH categories (56.9%, 54.0%, and 55.8% for AMH <1.1, 1.1-4.0, and >4.0 ng/mL, respectively) and AFC categories (56.3%, 54.8%, and 54.9% for AFC <7, 7-16, and >16, respectively). After adjustment, euploidy was modestly higher in the lowest AMH category (RR: 1.08; 95% confidence interval [CI]: 1.05, 1.11) but similar in the highest AMH category (RR: 1.00; 95% CI: 0.98, 1.02). Euploidy rates were comparable among AFC <7 and 7-16 (RR: 1.00; 95% CI: 0.98, 1.03) but slightly lower in AFC >16 (RR: 0.96; 95% CI: 0.95, 0.98). Both AMH and AFC levels were not significantly associated with live birth, clinical pregnancy, or implantation rates. CONCLUSION: Contrary to recent studies, lower AMH and AFC levels were not associated with a clinically significant decrease in embryo euploidy or live birth outcomes. These findings suggest that although AMH and AFC are useful for assessing ovarian reserve, they may have limited value in predicting embryo euploidy when considered independently of other factors, such as maternal age.
引用
- Eubanks A, Flannagan K, Le K, et al. Beyond numbers: antimüllerian hormone and antral follicle count are not independent predictors of embryo euploidy in in vitro fertilization with preimplantation genetic testing for aneuploidy. Fertil Steril. 2025. PMID: 40850506. doi:10.1016/j.fertnstert.2025.08.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。